ZELLUNA ASA
996713008ActivePioneering TCR-NK cell therapies to eliminate solid cancers effectively.
Oversigt
- 7
- Medarbejdere
- Ukendt
- Omsætning
- 2011
- Grundlagt
Nøglebeslutningstagere
Namir Hassan
Chief Executive Officer
Geir Christian Melen
Chief Financial Officer
Luise Weigand
Chief Scientific Officer
Michael Nishimura
Scientific Advisory Board Member
+15 flere kontakter i Funnelfeedr
Beskrivelse
Zelluna ASA is a biotechnology company focused on pioneering novel cell therapies for cancer treatment. Their primary mission is to eliminate solid cancers, which represent the largest cancer burden globally. They are developing a unique and proprietary TCR-NK (T cell receptor guided natural killer)...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Allmennaksjeselskap
- Momsnummer
- Ukendt
Beslutningstagere
19 kontakter i FunnelfeedrNamir Hassan
Chief Executive Officer
Geir Christian Melen
Chief Financial Officer
Luise Weigand
Chief Scientific Officer
Michael Nishimura
Scientific Advisory Board Member
Emilie Gauthy
Chief Technology Officer
Anders Holm
Chief Operating Officer and Head of Business Development
May Sabry
Scientific Advisory Board Member
Omid Hamid
Scientific Advisory Board Member
Eva-Lotta Allan
Board Member
Julia Ino
Head of Project Management
Bent Jakobsen
Board Member
Charlotte Sofie Bergsagel Berg-Svendsen
Board Member
Ulrike Köhl
Scientific Advisory Board Member
Øivind Foss
Head of Clinical Operations
Dirk Jäger
Scientific Advisory Board Member
Wolf Hervé Fridman
Scientific Advisory Board Member
Hans Ivar Robinson
Board Member
Joachim Midttun
Finance Manager
Andre kontakter
Anders Tuv
Advisor
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Ultimovacs AB
0 medarbejderePioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
BIO INVENTION AS
Clinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
CuraCell TX AB
5 medarbejdereEuropean biotech developing personalized T-cell therapies for solid cancer tumors.
CELLMOVER AS
6 medarbejderePre-clinical immunotherapy company optimizing immune cell targeting for cancer.
NUCLITHERA AS
9 medarbejdereDeveloping targeted alpha and beta emitters for metastatic cancer treatment.
Udforsk mere
Spørgsmål om ZELLUNA ASA
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo